• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of a new multidisciplinary therapy for the intractable, advanced hepatocellular carcinoma, targeting the intracellular signaling molecules.

Research Project

Project/Area Number 13470255
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionOsaka University

Principal Investigator

SAKON Masato  Osaka University Graduate School of Medicine, Associate Professor, 医学系研究科, 助教授 (40170659)

Co-Investigator(Kenkyū-buntansha) MONDEN Morito  Osaka University Graduate School of Medicine, Professor, 医学系研究科, 教授 (00127309)
NAKAMORI Syoji  Osaka University Graduate School of Medicine, Lecturer, 医学系研究科, 講師 (70294080)
NAGANO Hiroaki  Osaka University Graduate School of Medicine, Assistant Professor, 医学系研究科, 助手 (10294050)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥13,600,000 (Direct Cost: ¥13,600,000)
Fiscal Year 2002: ¥6,500,000 (Direct Cost: ¥6,500,000)
Fiscal Year 2001: ¥7,100,000 (Direct Cost: ¥7,100,000)
Keywordshepatocelluklar carcinoma / interferon-α / 5-FU / angiogenesis / interferon receptor / TRAIL / TRAIL receptor / 肝細胞癌 / IFN併用化学療法 / TRAIL受容体 / NK細胞 / インターフェロン-α / 5-fluorouracil / angiopoietin / TRAIL-receptor
Research Abstract

1) Relationship between antitumor effect and suppression of angiogenesis in human hepatoma cells - implanted nude mice receiving a combined 5-FU and interferon-alpha (IFN-alpha) therapy.
In human tumor cells-implanted nude mice, antitumor effect was compared by measuring tumor diameter among 4 treatment regimens, I.e., control, 5-FU, IFN-alpha and 5-FU + IFN-alpha. The antitumor effect was best observed in 5-FU + IFN-alpha group, and was significantly correlated with micro vessel density count in tumo r tissue. In addition, the involvement of various angiogenic factors including VEGF was examined by measuring mRNA or protein expression. Among angiogenic factors examined, the expression of angiopoietin 2 was most significantly correlated with angiogenesis in tumor tissues.
2) Antitumor effect through TRAIL/TRAIL receptor.
IFN-alpha and 5-FU enhanced TRAIL expression in peripheral mononuclear cells, and TRAIL receptor in cultured hepatoma cells. Among peripheral blood cells, NK cells and mononuclear cells were found to exert the cytotoxic effects on human hepatoma cells.
3) Expression of IFN-alpha receptor (IFNR) in human hepatoma tissues.
The protein expression of IFNR in human hepatoma tissues was investigated immunohistochemically in 20 patients receiving combined intra-arterial 5-FU and systemic IFN-alpha therapy. The clinical antitumor effect was observed in all of 12 IFNR positive patients while none of 8 IFNR negative patients show the clinica; response. These results suggest the significant role of IFNR in the antitumor signaling pathway of IFN-alpha and 5-FU.

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Sakon M., Nagano H.et al.: "Combined intraarterial 5-Fluorouracil and Subcutaneous interferon-α therapy advanced hepatocellular carcinoma with tumor thrombi in the major portal branches"Cancer. 94(2). 435-442 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 山本為義, 左近賢人 他: "特集/肝疾患におけるインターフェロン治療の新たな展開. 肝細胞癌 進行癌の治療(化学療法との併用)"肝胆膵. 45(6). 1053-1061 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 永野浩昭, 左近賢人 他: "インターフェロン-α併用動注化学療法による肝細胞癌の治療"医学と薬学. 47. 77-80 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 永野浩昭, 左近賢人 他: "当科における肝細胞癌の診療方針"肝臓. 43(11). 524-526 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 永野浩昭, 左近賢人 他: "肝細胞癌に対する新治療法の開発研究"日本臨床. 60(11). 2237-2244 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 山本為義, 左近賢人 他: "門脈内腫瘍栓を伴う肝細胞癌に対する動注化学療法"Practical Oncology. 15(4). (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Sakon M., Nagano H. et al.: "Combined intraarterial 5-Fluorouracil and Subcutaneous interferon-α therapy advanced hepatocellular carcinoma with tumor thrombi in the major portal branches."Cancer. 94(2). 435-442 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Sakon M., et al.: "Combined intraarterial 5-fluorouracil and subcutaneous interferon-αtherapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches"Cancer. 94. 435-442 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ito Y., Sakon M., et al.: "Expression of heparin binding epidermal growth factor-like growth factor in hepatocellular carcinoma : an immunohistochemical study"Oncol Rep. 8. 903-907 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ito Y., Sakon M., et al.: "Expression of p57/Kip2 Protein in Hepatocellular Carcinoma"Oncology. 61. 221-225 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 永野浩昭, 左近賢人, 他: "肝細胞(Hepatocellular Carcinoma)の集学的治療"癌の臨床. 47. 29-33 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 永野浩昭, 左近賢人, 他: "肝癌 -進行肝癌の治療-"肝胆膵. 43. 945-949 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 永野浩昭, 左近賢人, 他: "IFN併用動注化学療法"日本臨床. 59. 748-752 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 新井 勲, 左近賢人, 他: "アンジオスタチン、エンドスタチンその他の血管新生物質"Biomedical Perspectives. 10. 53-57 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi